Boundless Bio, Inc. (BOLD)
2.63
+0.01
(+0.38%)
USD |
NASDAQ |
Oct 05, 12:21
Boundless Bio 1 Year Total Returns (Daily) : 116.5% for Oct. 2, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 02, 2026 | 116.5% |
| October 01, 2026 | 110.6% |
| September 30, 2026 | 104.1% |
| September 29, 2026 | 113.3% |
| September 28, 2026 | 128.9% |
| September 25, 2026 | 135.4% |
| September 24, 2026 | 127.1% |
| September 23, 2026 | 138.9% |
| September 22, 2026 | 154.9% |
| September 21, 2026 | 148.2% |
| September 18, 2026 | 146.5% |
| September 17, 2026 | 145.6% |
| September 16, 2026 | 145.2% |
| September 15, 2026 | 144.3% |
| September 14, 2026 | 147.0% |
| September 11, 2026 | 144.0% |
| September 10, 2026 | 144.8% |
| September 09, 2026 | 147.8% |
| September 08, 2026 | 148.7% |
| September 04, 2026 | 154.0% |
| September 03, 2026 | 149.6% |
| September 02, 2026 | 151.3% |
| September 01, 2026 | 158.0% |
| August 31, 2026 | 150.9% |
| August 28, 2026 | 148.2% |
| Date | Value |
|---|---|
| August 27, 2026 | 150.9% |
| August 26, 2026 | 155.7% |
| August 25, 2026 | 160.2% |
| August 24, 2026 | 153.0% |
| August 21, 2026 | 163.2% |
| August 20, 2026 | 154.4% |
| August 19, 2026 | 157.7% |
| August 18, 2026 | 144.4% |
| August 17, 2026 | 144.0% |
| August 14, 2026 | 141.9% |
| August 13, 2026 | 137.2% |
| August 12, 2026 | 148.2% |
| August 11, 2026 | 147.7% |
| August 10, 2026 | 161.1% |
| August 07, 2026 | 153.5% |
| August 06, 2026 | 140.7% |
| August 05, 2026 | 137.3% |
| August 04, 2026 | 125.4% |
| August 03, 2026 | 121.6% |
| July 31, 2026 | 111.0% |
| July 30, 2026 | 110.1% |
| July 29, 2026 | 108.4% |
| July 28, 2026 | 99.19% |
| July 27, 2026 | 96.05% |
| July 24, 2026 | 105.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -6.69% |
| Alnylam Pharmaceuticals, Inc. | -52.34% |
| Savara, Inc. | 37.82% |
| Vericel Corp. | 27.38% |
| Biogen, Inc. | 41.63% |